Merus Pioneering Bispecific Antibodies Ton Logtenberg, Founder President and Chief Executive Officer June 4, 2019 2 Disclaimer This presentation (including any oral commentary that accompanies this presentation) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements rega ...